QUINOLONE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITED ACTIVITY
申请人:Shenzhen Chipscreen Biosciences Co., Ltd.
公开号:EP3858813A1
公开(公告)日:2021-08-04
Provided is a quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity, specifically, provided is a compound of general Formula (I) or pharmaceutically acceptable salt thereof, its pharmaceutical composition, preparation method and use in the manufacture of a medicament for immunomodulating and preventing and/or treating of a disease associated with IDO expression abnormality and/or tryptophan metabolism abnormality. Also provided is use of a combination medication of the quinoline derivative and HDAC inhibitor and its use in the manufacture of an anti-tumor drug.
A-X-B-Y-M Formula (I)
QUINOLINE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITORY ACTIVITY
申请人:SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
公开号:US20210379052A1
公开(公告)日:2021-12-09
Provided is a quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity, specifically, provided is a compound of general Formula (I) or pharmaceutically acceptable salt thereof, its pharmaceutical composition, preparation method and use in the manufacture of a medicament for immunomodulating and preventing and/or treating of a disease associated with IDO expression abnormality and/or tryptophan metabolism abnormality. Also provided is use of a combination medication of the quinoline derivative and HDAC inhibitor and its use in the manufacture of an anti-tumor drug.
A-X—B—Y-M Formula (I)
Shikhmamedbekova,A.Z. et al., Journal of Organic Chemistry USSR (English Translation), 1977, vol. 13, p. 899 - 905
作者:Shikhmamedbekova,A.Z. et al.
DOI:——
日期:——
Visible-light-induced selective aerobic oxidation of sp<sup>3</sup> C–H bonds catalyzed by a heterogeneous AgI/BiVO<sub>4</sub> catalyst